These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21951607)

  • 1. The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design.
    Benoit E; O'Donnell TF; Iafrati MD; Asher E; Bandyk DF; Hallett JW; Lumsden AB; Pearl GJ; Roddy SP; Vijayaraghavan K; Patel AN
    J Transl Med; 2011 Sep; 9():165. PubMed ID: 21951607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia.
    Iafrati MD; Hallett JW; Geils G; Pearl G; Lumsden A; Peden E; Bandyk D; Vijayaraghava KS; Radhakrishnan R; Ascher E; Hingorani A; Roddy S
    J Vasc Surg; 2011 Dec; 54(6):1650-8. PubMed ID: 22019148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia.
    Powell RJ; Comerota AJ; Berceli SA; Guzman R; Henry TD; Tzeng E; Velazquez O; Marston WA; Bartel RL; Longcore A; Stern T; Watling S
    J Vasc Surg; 2011 Oct; 54(4):1032-41. PubMed ID: 21684715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnic minorities with critical limb ischemia derive equal amputation risk reduction from autologous cell therapy compared with whites.
    Wang SK; Green LA; Gutwein AR; Drucker NA; Babbey CM; Gupta AK; Fajardo A; Motaganahalli RL; Wilson MG; Murphy MP
    J Vasc Surg; 2018 Aug; 68(2):560-566. PubMed ID: 29503004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials.
    Teraa M; Sprengers RW; van der Graaf Y; Peters CE; Moll FL; Verhaar MC
    Ann Surg; 2013 Dec; 258(6):922-9. PubMed ID: 23426345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current accepted hemodynamic criteria for critical limb ischemia do not accurately stratify patients at high risk for limb loss.
    Vallabhaneni R; Kalbaugh CA; Kouri A; Farber MA; Marston WA
    J Vasc Surg; 2016 Jan; 63(1):105-12. PubMed ID: 26412436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: the BONe Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI).
    Amann B; Lüdemann C; Rückert R; Lawall H; Liesenfeld B; Schneider M; Schmidt-Lucke J
    Vasa; 2008 Nov; 37(4):319-25. PubMed ID: 19003741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endovascular Therapy Versus Bypass Surgery as First-Line Treatment Strategies for Critical Limb Ischemia: Results of the Interim Analysis of the CRITISCH Registry.
    Bisdas T; Borowski M; Stavroulakis K; Torsello G;
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2557-2565. PubMed ID: 28007205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia.
    Moazzami K; Moazzami B; Roohi A; Nedjat S; Dolmatova E
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD008347. PubMed ID: 25525690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia.
    Gupta PK; Chullikana A; Parakh R; Desai S; Das A; Gottipamula S; Krishnamurthy S; Anthony N; Pherwani A; Majumdar AS
    J Transl Med; 2013 Jun; 11():143. PubMed ID: 23758736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions.
    Iida O; Soga Y; Hirano K; Kawasaki D; Suzuki K; Miyashita Y; Terashi H; Uematsu M
    J Vasc Surg; 2012 Feb; 55(2):363-370.e5. PubMed ID: 22051875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease.
    Amann B; Luedemann C; Ratei R; Schmidt-Lucke JA
    Cell Transplant; 2009; 18(3):371-80. PubMed ID: 19500466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of therapeutic angiogenesis as a novel treatment in patients with critical limb ischemia.
    Lara-Hernandez R; Lozano-Vilardell P; Blanes P; Torreguitart-Mirada N; Galmés A; Besalduch J
    Ann Vasc Surg; 2010 Feb; 24(2):287-94. PubMed ID: 20142004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia.
    Murphy MP; Lawson JH; Rapp BM; Dalsing MC; Klein J; Wilson MG; Hutchins GD; March KL
    J Vasc Surg; 2011 Jun; 53(6):1565-74.e1. PubMed ID: 21514773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amputation-free Survival in Patients with Critical Limb Ischemia Treated with Paclitaxel-eluting Stents and Paclitaxel-coated Balloons.
    Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K
    Ann Vasc Surg; 2020 Jan; 62():8-14. PubMed ID: 31207400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone Marrow derived Cell Therapy in Critical Limb Ischemia: A Meta-analysis of Randomized Placebo Controlled Trials.
    Peeters Weem SM; Teraa M; de Borst GJ; Verhaar MC; Moll FL
    Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):775-83. PubMed ID: 26460286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous bone marrow mononuclear cell implantation therapy is an effective limb salvage strategy for patients with severe peripheral arterial disease.
    Franz RW; Shah KJ; Pin RH; Hankins T; Hartman JF; Wright ML
    J Vasc Surg; 2015 Sep; 62(3):673-80. PubMed ID: 26304481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local intramuscular transplantation of autologous bone marrow mononuclear cells for critical lower limb ischaemia.
    Moazzami B; Mohammadpour Z; Zabala ZE; Farokhi E; Roohi A; Dolmatova E; Moazzami K
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD008347. PubMed ID: 35802393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia.
    Madaric J; Klepanec A; Valachovicova M; Mistrik M; Bucova M; Olejarova I; Necpal R; Madaricova T; Paulis L; Vulev I
    Stem Cell Res Ther; 2016 Aug; 7(1):116. PubMed ID: 27530339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous bone marrow stem cell transplantation in critical limb ischemia: a meta-analysis of randomized controlled trials.
    Liu FP; Dong JJ; Sun SJ; Gao WY; Zhang ZW; Zhou XJ; Yang L; Zhao JY; Yao JM; Liu M; Liao L
    Chin Med J (Engl); 2012 Dec; 125(23):4296-300. PubMed ID: 23217403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.